M&A Deal Summary |
|
---|---|
Date | 2024-03-14 |
Target | Finbiosoft |
Sector | Software |
Buyer(s) | BYG4lab |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
BYG4lab is a software publisher specializing in medical biology middleware solutions. The Company provides a number of key benefits, including but not limited to: improving workflow management, making instrument integration more efficient, handling mega lab configuration, designing personalized dashboards, maximizing automatic validation, and managing quality control. The Company addresses both Central Lab and Point of Care testing, as well as all disciplines in the field of medical biology – immunochemistry, hematology, molecular, microbiology. BYG4lab was founded in 1982 and is based in L'Union, France.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Software) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 1 |
Country (Finland) | 1 of 1 |
Year (2024) | 1 of 1 |